[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353748-105":59,"doc-detail-353748-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","prognostic-value-of-pd-l1-expression-on-tumor-infiltrating-immune-cells-and-neutrophil-to-lymphocyte-ratio-in-patients-with-biliary-tract-cancer","Prognostic value of PD-L1 expression on tumor-infiltrating immune cells and neutrophil-to-lymphocyte ratio in patients with biliary tract cancer","","Expression of Programmed Death-Ligand 1 (PD-L1) on tumor-infiltrating immune cells (TIICs) and the neutrophil-to-lymphocyte ratio (NLR) are evaluated as prognostic markers in biliary tract cancer. The study enrolled 239 patients (2017–2020) and assessed PD-L1 by immunohistochemistry, while survival outcomes included overall survival (OS) and disease-free survival (DFS). Exploratory subgroup results link high PD-L1 on TIICs and elevated dynamic NLR with worse post-recurrence survival.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-value-of-pd-l1-expression-on-tumor-infiltrating-immune-cells-and-neutrophil-to-lymphocyte-ratio-in-patients-with-biliary-tract-cancer/353748/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-value-of-pd-l1-expression-on-tumor-infiltrating-immune-cells-and-neutrophil-to-lymphocyte-ratio-in-patients-with-biliary-tract-cancer/353748.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main objective of this study in biliary tract cancer?","Question",{"text":113,"@type":114},"To examine PD-L1 expression on tumor-infiltrating immune cells (TIICs) and to assess how PD-L1 and NLR influence immunotherapy outcomes after biliary tract cancer recurrence.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was PD-L1 expression on TIICs measured?",{"text":118,"@type":114},"PD-L1 expression on TIICs was measured using immunohistochemical analysis on pathological tissue sections from enrolled patients.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the study find regarding NLR and survival outcomes?",{"text":122,"@type":114},"Elevated NLR was associated with reduced DFS and diminished OS, with risk estimates reported for time points one week and one month prior to and after recurrence.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353748,1790121888,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Original Research PUBLISHED 09 February 2026 DOI 10.3389/fimmu.2025.1729542  \nOPEN ACCESS  \nEDITED BY  \nShigao Huang,  \nAir Force Medical University, China  \nREVIEWED BY  \nJie Xian,  \nUniversity of California, San Diego, United States  \nFatemeh Vatankhah,  \nUniversity of Miami, United States  \n*CORRESPONDENCE  \nXiaojun Lin  \n [linxj@sysucc.org.cn](linxj@sysucc.org.cn)[ ](linxj@sysucc.org.cn)Jianzhong Cao  \n [caojz@sysucc.org.cn](caojz@sysucc.org.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 21 October 2025  \nREVISED 14 December 2025  \nACCEPTED 31 December 2025  \nPUBLISHED 09 February 2026  \nCITATION  \nChen S, Huang G, Yao Z, Lin X and Cao J (2026) Prognostic value of PD-L1 expression on tumor-inﬁltrating immune cells and neutrophil-to-lymphocyte ratio in patients with biliary tract cancer.  \nFront. Immunol. 16:1729542 .  \ndoi: 10.3389/fimmu.2025.1729542  \nCOPYRIGHT  \n© 2026 Chen, Huang, Yao, Lin and Cao. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nPrognostic value of PD-L1 expression on tumor-inﬁltrating immune cells and neutrophilto-lymphocyte ratio in patients with biliary tract cancer  \nShang Chen 1,2†, Guizhong Huang 1†, Zehui Yao 1†, Xiaojun Lin 1* and Jianzhong Cao 1*  \n1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China, 2 Department of Medical Oncology, Henan Cancer Hospital, Afﬁliated to Zhengzhou University, Zhengzhou, Henan, China  \nBackground: The expression of Programmed Death-Ligand 1 (PD-L1) on tumorinﬁltrating immune cells (TIICs), plays a crucial role in tumor progression and immune evasion, impacting both the natural immune response and immunetargeted therapeutic strategies. The neutrophil-to-lymphocyte ratio (NLR) has also gained attention as a potential predictive biomarker for immunotherapy efﬁcacy, as it may correlate with treatment outcomes.  \nObjective: To examine the expression of PD-L1 on TIICs and assess the inﬂuence of PD-L1 and NLR on immunotherapy outcomes following biliary tract cancers (BTC) recurrence.  \nMethods: From January 1, 2017, to January 1, 2020, this study enrolled 239 patients from the Department of Pancreaticobiliary Surgery at Sun Yat-sen University Cancer Center. Immunohistochemical analysis of PD-L1 on TIICs was conducted on pathological tissue sections from these patients. Clinical data, including overall survival (OS), disease-free survival (DFS), and pathological ﬁndings, were collected during follow-up. Statistical analyses were performed to assess outcomes related to the study objectives . Furthermore, data from The Cancer Genome Atlas (TCGA) were utilized to examine PD-L1 expression proﬁles and related information.  \nResults: Tumor stage did not differ signiﬁcantly (P = 0 . 173), while metastasis stage approached signiﬁcance (P = 0.093), with a higher proportion of M0 cases in the PD-L1 low group. Univariate analysis revealed vascular tumor thrombus, tumor differentiation, node stage, and preoperative CA199 levels as factors associated with DFS. Notably, vascular tumor thrombus (HR = 1 .791, P = 0 . 002), moderate tumor differentiation (HR = 0.537, P = 0.002), and elevated preoperative CA199 levels (>35, HR = 1 . 624, P = 0 . 009) emerged as signiﬁcant risk factors. Elevated NLR demonstrated a signiﬁcant association with reduced DFS (HR = 1.54, p = 0.017 one week prior; HR = 1.70, p = 0.007 one month after) and diminished OS (HR = 2 .30, p \u003C 0 . 001 one week prior; HR = 1 . 94, p = 0 . 005 one month after) . Exploratory analysis in a limi","cbCaip8Rf64i1dYJ","https://ap.wps.com/l/cbCaip8Rf64i1dYJ","pdf",6050329,17,"English","# Background\n## PD-L1 and immune checkpoint context\n## Tumor microenvironment and TIICs\n# Objective\n# Methods\n## Patient cohort and follow-up\n## PD-L1 assessment\n## Statistical and TCGA analyses\n# Results\n## DFS risk factors\n## NLR association with OS/DFS\n## Exploratory immunotherapy subgroup\n# Conclusion","[{\"question\":\"What was the main objective of this study in biliary tract cancer?\",\"answer\":\"To examine PD-L1 expression on tumor-infiltrating immune cells (TIICs) and to assess how PD-L1 and NLR influence immunotherapy outcomes after biliary tract cancer recurrence.\"},{\"question\":\"How was PD-L1 expression on TIICs measured?\",\"answer\":\"PD-L1 expression on TIICs was measured using immunohistochemical analysis on pathological tissue sections from enrolled patients.\"},{\"question\":\"What did the study find regarding NLR and survival outcomes?\",\"answer\":\"Elevated NLR was associated with reduced DFS and diminished OS, with risk estimates reported for time points one week and one month prior to and after recurrence.\"}]","Prognostic value of PD-L1 expression on tumor-infiltrating immune cells and neutrophil-to-lymphocyte ratio in patients with biliary tract cancer | PDF",1790107043,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/953f7484646203ab747a8e3b925ecd43.webp",983,1389,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48ae4659ba2f0a0aeeb87cc8a6fdde27.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b51b2a0c0113f942eda4fbeac5f90a6f.webp",981,1386,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fac47efe3f9f10381c44a39bd1cabe6f.webp",980,1385]